Abstract
Duloxetine, a balanced and potent dual reuptake inhibitor of serotonin and norepinephrine, is the new approved drug for the pharmacotherapy of diabetic peripheral neuropathic pain. It extend the spectrum of adjuvant analgesics.
Duloxetine, a balanced and potent dual reuptake inhibitor of serotonin and norepinephrine, is the new approved drug for the pharmacotherapy of diabetic peripheral neuropathic pain. It extend the spectrum of adjuvant analgesics.